Complejo Asistencial Universitario de Burgos-ko ikertzaileekin lankidetzan egindako argitalpenak (20)

2024

  1. Cómo estimar la composición corporal en la enfermedad de Huntington. Estudio transversal y observacional con bioimpedancia de múltiples frecuencias

    Revista de neurologia, Vol. 78, Núm. 1, pp. 17-25

  2. Novel risk loci for COVID-19 hospitalization among admixed American populations

    eLife, Vol. 13

  3. Validation of ActiGraph and Fitbit in the assessment of energy expenditure in Huntington's disease

    Gait and Posture, Vol. 109, pp. 89-94

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

2022

  1. Accelerometer Cut-Points for Physical Activity Assessment in Adults with Mild to Moderate Huntington’s Disease: A Cross-Sectional Multicentre Study

    International Journal of Environmental Research and Public Health, Vol. 19, Núm. 22

  2. Novel genes and sex differences in COVID-19 severity

    Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806

2021

  1. Adaptation to change questionnaire for nurses: Validation and new needs in the context of COVID-19

    Healthcare (Switzerland), Vol. 9, Núm. 12

  2. F36 DXA, BIA, anthropometry and skin folds methodology in body composition

    Journal of Neurology, Neurosurgery & Psychiatry: EHDNAbstracts 2021, Vol. 92, Núm. Suppl 1

2020

  1. Design and validation of the adaptation to change questionnaire: New realities in times of covid-19

    International Journal of Environmental Research and Public Health, Vol. 17, Núm. 15, pp. 1-15

  2. Effect of antiviral treatment in older patients hospitalized with confirmed influenza

    Antiviral Research, Vol. 178

2018

  1. Estimación de la fracción atribuible poblacional debida a la obesidad en los ingresos hospitalarios por gripe valorada según el índice de masa corporal (IMC) y el CUN-BAE

    Semergen: revista española de medicina de familia, Núm. 2, pp. 100-106

  2. Repeated influenza vaccination for preventing severe and fatal influenza infection in older adults: A multicentre case-control study

    CMAJ, Vol. 190, Núm. 1, pp. E3-E12

2017

  1. Costs associated with influenza-related hospitalization in the elderly

    Human Vaccines and Immunotherapeutics, Vol. 13, Núm. 2, pp. 412-416

  2. Effectiveness of 23-valent pneumococcal polysaccharide vaccination in preventing community-acquired pneumonia hospitalization and severe outcomes in the elderly in Spain

    PLoS ONE, Vol. 12, Núm. 2

  3. Factors associated with 30-day mortality in elderly inpatients with community acquired pneumonia during 2 influenza seasons

    Human Vaccines and Immunotherapeutics, Vol. 13, Núm. 2, pp. 450-455

  4. The effectiveness of influenza vaccination in preventing hospitalisations of elderly individuals in two influenza seasons: A multicentre case–control study, Spain, 2013/14 and 2014/15

    Eurosurveillance, Vol. 22, Núm. 34

2016

  1. Factors associated with pneumococcal polysaccharide vaccination of the elderly in Spain: A cross-sectional study

    Human Vaccines and Immunotherapeutics, Vol. 12, Núm. 7, pp. 1891-1899

2013

  1. Risk factors and effectiveness of preventive measures against influenza in the community

    Influenza and other Respiratory Viruses, Vol. 7, Núm. 2, pp. 177-183

2012

  1. Effectiveness of hand hygiene and provision of information in preventing influenza cases requiring hospitalization

    Preventive Medicine, Vol. 54, Núm. 6, pp. 434-439

  2. Prognosis of hospitalized patients with 2009 H1N1 influenza in Spain: Influence of neuraminidase inhibitors

    Journal of Antimicrobial Chemotherapy, Vol. 67, Núm. 7, pp. 1739-1745